Monday, July 25, 2016

BRIEF-Epirus Biopharmaceuticals entered settlement satisfaction amendment with Livzon Mabpharm

* On July 15, co entered into a settlement satisfaction

amendment with Livzon Mabpharm Inc - SEC filing

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)